Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Breast cancer cells promote CD169+ macrophage-associated immunosuppression through JAK2-mediated PD-L1 upregulation on macrophages

Published:2020-01 Issue: Volume:78 Page:106012
ISSN:1567-5769
Container-title:International Immunopharmacology
language:en
Short-container-title:International Immunopharmacology

Author:

Jing Weiqiang,Guo Xing,Wang Ganyu,Bi Yuxuan,Han Lihui,Zhu Qingfen,Qiu Chunhong,Tanaka Masato,Zhao Yunxue

Funder

Shandong Province Science and Technology Program

The Fundamental Research Funds of Shandong University

Publisher

Elsevier BV

Subject

Pharmacology,Immunology,Immunology and Allergy

Reference73 articles.

1. Cancer statistics, 2019;Siegel;CA. Cancer J. Clin.,2019

2. A single-cell atlas of the tumor and immune ecosystem of human breast cancer;Wagner;Cell,2019

3. The role of HER2, EGFR, and other receptor tyrosine kinases in breast cancer;Hsu;Cancer Metastasis Rev.,2016

4. Glucocorticoids promote breast cancer metastasis;Obradović;Nature,2019

5. Tinagl1 suppresses triple-negative breast cancer progression and metastasis by simultaneously inhibiting Integrin/FAK and EGFR Signaling;Shen;Cancer Cell,2019

Cited by 48 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhibition of STAT3 by 2-Methoxyestradiol suppresses M2 polarization and protumoral functions of macrophages in breast cancer;BMC Cancer;2024-09-10

2. The complex role of macrophages in pancreatic cancer tumor microenvironment: a review on cancer progression and potential therapeutic targets;Discover Oncology;2024-08-26

3. CAR Macrophages: a promising novel immunotherapy for solid tumors and beyond;Biomarker Research;2024-08-23

4. Glioma-Associated Sialoglycans Drive the Immune Suppressive Phenotype and Function of Myeloid Cells;Pharmaceutics;2024-07-19

5. Targeting a STING agonist to perivascular macrophages in prostate tumors delays resistance to androgen deprivation therapy;Journal for ImmunoTherapy of Cancer;2024-07

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3